Using Augmented Reality to Improve Gait and Reduce Anxiety in Parkinson's Disease
Investigate the Effect of AR Environment Stimulation on Gait, Anxiety and Brain Connectivity of Individuals With Parkinson Disease
This study is testing a new training program using augmented reality and heart rate feedback to see if it can help people with Parkinson's disease walk better and feel less anxious.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 90 (estimated) |
| Ages | 20 Years and up |
| Sex | All |
| Sponsor | Chang Gung University Academic / other |
| Locations | 1 site (Taoyuan) |
| Trial ID | NCT06367101 on ClinicalTrials.gov |
What this trial studies
This project aims to enhance gait and alleviate non-motor symptoms such as anxiety and stress in patients with Parkinson's disease through a novel intervention that combines heart rate variability (HRV) feedback with Augmented Reality (AR) training. The study is based on the premise that improving HRV, which reflects the adaptability of the autonomic nervous system, can lead to better motor functions and reduced anxiety. Participants will engage in AR training designed to address specific gait impairments while receiving real-time HRV feedback. The approach leverages Gentile's motor skill taxonomy to create a structured rehabilitation program that evaluates and improves both motor and non-motor symptoms.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals diagnosed with Parkinson's disease who do not have any musculoskeletal injuries or osteoporosis.
Not a fit: Patients with musculoskeletal injuries on their legs, osteoporosis, or any peripheral or central nervous system injury or disease may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve the quality of life for patients with Parkinson's disease by enhancing their gait and reducing anxiety.
How similar studies have performed: Other studies have shown promising results using HRV feedback and AR in rehabilitation, suggesting that this approach may be effective, though it remains a relatively novel application in the context of Parkinson's disease.
Eligibility criteria
Show full inclusion / exclusion criteria
Health subjects: Exclusion Criteria: * Musculoskeletal injuries on legs. * Osteoporosis. PD subjects: Inclusion Criteria: - Clinical diagnosis of Parkinson disease. Exclusion Criteria: * Musculoskeletal injuries on legs * Osteoporosis. * Any peripheral or central nervous system injury or disease patients.
Where this trial is running
Taoyuan
- Chang Gung University — Taoyuan, Taiwan (Recruiting)
Study contacts
- Study coordinator: Ya-Ju Chang, PhD
- Email: yjchang@mail.cgu.edu.tw
- Phone: +88632118800
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.